Tumor suppressor genes in normal and malignant hematopoiesis (Q34658581)

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

p53 mutation and expression in lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Blocking oncogenic Ras signaling for cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

The spectrum of molecular alterations in the evolution of chronic myelocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Mutation analysis of the WT1 gene in sporadic childhood leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Monoallelic p53 deletion in chronic lymphocytic leukemia detected by interphase cytogenetics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Retinoblastoma-repression of E2F-dependent transcription depends on the ability of the retinoblastoma protein to interact with E2F and is abrogated by the adenovirus E1A oncoprotein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Enhanced phosphorylation of p53 by ATM in response to DNA damage

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Molecular analysis of the retinoblastoma (RB1) gene in acute myeloid leukemia patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Significance of p53 mutations in patients with chronic lymphocytic leukemia: a sequential study of 30 patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Alterations of P53 and RB genes and the evolution of the accelerated phase of chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Chromosome 20 deletions in myeloid malignancies: reduction of the common deleted region, generation of a PAC/BAC contig and identification of candidate genes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Patient with 13 Chromosome Deletion: Evidence That the Retinoblastoma Gene Is a Recessive Cancer Gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

The translocation t(8;16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB-binding protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Retinoblastoma protein recruits histone deacetylase to repress transcription

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Evidence for a new tumour suppressor locus (DBM) in human B-cell neoplasia telomeric to the retinoblastoma gene.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

BCL10 is not the gene inactivated by mutation in the 1p22 deletion region in mantle cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Trisomy 12 and p53 deletion in chronic lymphocytic leukemia detected by fluorescence in situ hybridization: association with morphology and resistance to conventional chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Hemizygous p16(INK4A) deletion in pediatric acute lymphoblastic leukemia predicts independent risk of relapse

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Failure of embryonic hematopoiesis and lethal hemorrhages in mouse embryos heterozygous for a knocked-in leukemia gene CBFB-MYH11.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

The unexplored 5q13 locus: a role in hematopoietic malignancies.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

ETV6 is the target of chromosome 12p deletions in t(12;21) childhood acute lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

High-resolution allelotype analysis of childhood B-lineage acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Identification of a human histone acetyltransferase related to monocytic leukemia zinc finger protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

The E2F transcription factor is a cellular target for the RB protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

p53 gene mutations and rearrangements in non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Methylation of p15 and p16 genes in acute promyelocytic leukemia: potential diagnostic and prognostic significance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Methylation of p15 and p16 genes in adult acute leukemia: lack of prognostic significance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Mutations with loss of heterozygosity of p53 are common in therapy-related myelodysplasia and acute myeloid leukemia after exposure to alkylating agents and significantly associated with deletion or loss of 5q, a complex karyotype, and a poor progno

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Genetic alterations of the retinoblastoma-related gene RB2/p130 identify different pathogenetic mechanisms in and among Burkitt's lymphoma subtypes.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Requirement for a functional Rb-1 gene in murine development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Analysis of p53 gene deletions in patients with non-Hodgkin's lymphoma by dual-colour fluorescence in-situ hybridization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Modulation of retinoblastoma gene in normal adult hematopoiesis: peak expression and functional role in advanced erythroid differentiation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Genetic events in the development of Wilms' tumor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Wilms' tumor gene product WT1 arrests macrophage differentiation of HL-60 cells through its zinc-finger domain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Repression of the transforming growth factor-beta 1 gene by the Wilms' tumor suppressor WT1 gene product

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Molecular abnormalities in chronic myeloid leukemia: deregulation of cell growth and apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Recurring chromosome abnormalities in Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Repression of the insulin-like growth factor II gene by the Wilms tumor suppressor WT1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

The regulation of E2F by pRB-family proteins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Regulation of G(1) cyclin-dependent kinases in the mammalian cell cycle

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

WAF1, a potential mediator of p53 tumor suppression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

The Wilms tumor suppressor WT1 directs stage-specific quiescence and differentiation of human hematopoietic progenitor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Loss of heterozygosity on chromosome 5 in adults with acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

The prognostic significance of p16(INK4a)/p14(ARF) locus deletion and MDM-2 protein expression in adult acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Comparative analysis of p73 and p53 regulation and effector functions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

p53 in chronic myelogenous leukemia in acute phase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Hereditary and acquired p53 gene mutations in childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Elevated levels of MDM-2 and p53 expression are associated with high grade non-Hodgkin's lymphomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Lineage-specific regulation of cell cycle control gene expression during haematopoietic cell differentiation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Genetic lesions associated with blastic transformation of polycythemia vera and essential thrombocythemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Genetic analysis of p53 and RB1 tumor-suppressor genes in blast crisis of chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Wilms' tumour gene (wt1) expression at diagnosis has no prognostic relevance in childhood acute lymphoblastic leukaemia treated by an intensive chemotherapy protocol

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Human platelet-derived growth factor A chain is transcriptionally repressed by the Wilms tumor suppressor WT1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Delineation of a 6 cM commonly deleted region in childhood acute lymphoblastic leukemia on the 6q chromosomal arm.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Homozygous inactivation of WT1 in a Wilms' tumor associated with the WAGR syndrome.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Conjunction dysfunction: CBP/p300 in human disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Inhibition of growth of human leukemia cell lines by retrovirally expressed wild-type p16INK4A.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Mutations in the gene encoding the transcription factor CCAAT/enhancer binding protein alpha in myelodysplastic syndromes and acute myeloid leukemias

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

De novo methylation of tumor suppressor gene p16/INK4a is a frequent finding in multiple myeloma patients at diagnosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Induction of Rb-associated protein (RbAp46) by Wilms' tumor suppressor WT1 mediates growth inhibition

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Overexpression of MDM2 in acute childhood lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

The activation domain of transcription factor PU.1 binds the retinoblastoma (RB) protein and the transcription factor TFIID in vitro: RB shows sequence similarity to TFIID and TFIIB

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

CCAAT/enhancer-binding protein-alpha cooperates with p21 to inhibit cyclin-dependent kinase-2 activity and induces growth arrest independent of DNA binding

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Extensive analysis of the retinoblastoma gene in adult T cell leukemia/lymphoma (ATL)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

p53 gene rearrangements in chronic myelocytic leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Frequent loss of heterozygosity in the region of D1S450 at 1p36.2 in myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Mutation analysis of the DNA-damage checkpoint gene CHK2 in myelodysplastic syndromes and acute myeloid leukemias

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

p53 mutations in human cancers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Distinct genetic involvement of the TP53 gene in therapy-related leukemia and myelodysplasia with chromosomal losses of Nos 5 and/or 7 and its possible relationship to replication error phenotype

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Genetic heterogeneity in familial acute myelogenous leukemia: evidence for a second locus at chromosome 16q21-23.2.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Mutation analysis of the WT1 gene in myelodysplastic syndromes.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

P53 gene mutations in acute myelogenous leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Mutations of the p53 gene as a prognostic factor in aggressive B-cell lymphoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Expression of Wilms tumor gene (WT1) in children with acute leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Mutations of the Smad4 gene in acute myelogeneous leukemia and their functional implications in leukemogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

DCC protein expression in hematopoietic cell populations and its relation to leukemogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Frequent microsatellite instability and BAX mutations in T cell acute lymphoblastic leukemia cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Frequent clonal loss of heterozygosity (LOH) in the chromosomal region 1p32 occurs in childhood T cell acute lymphoblastic leukemia (T-ALL) carrying rearrangements of the TAL1 gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Effects of an Rb mutation in the mouse

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Tumour predisposition in mice heterozygous for a targeted mutation in Nf1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Potential role for concurrent abnormalities of the cyclin D1, p16CDKN2 and p15CDKN2B genes in certain B cell non-Hodgkin's lymphomas. Functional studies in a cell line (Granta 519).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

The retinoblastoma gene (rb1) in acute myeloid leukaemia: analysis of gene rearrangements, protein expression and comparison of disease outcome.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Overexpression of Mdm2 in mice reveals a p53-independent role for Mdm2 in tumorigenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Clonal deleterious mutations in the IkappaBalpha gene in the malignant cells in Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

A cell cycle regulator potentially involved in genesis of many tumor types

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Lack of CD54 expression and mutation of p53 gene relate to the prognosis of childhood Burkitt's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

mdm-2 oncogene expression in non-Hodgkin's lymphomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Alterations of the p53, p21, p16, p15 and RAS genes in childhood T-cell acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Rapid ATM-dependent phosphorylation of MDM2 precedes p53 accumulation in response to DNA damage

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Mutation and cancer: statistical study of retinoblastoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Mutations in the p53 gene are not limited to classic 'hot spots' and are not predictive of p53 protein expression in high-grade non-Hodgkin's lymphoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Allelotyping of acute myelogenous leukemia: loss of heterozygosity at 7q31.1 (D7S486) and q33-34 (D7S498, D7S505)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Altered expression of retinoblastoma (RB) protein in acute myelogenous leukemia does not result from methylation of the Rb promotor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Loss of heterozygosity and heterogeneity of its appearance and persisting in the course of acute myeloid leukemia and myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

MDM2 gene amplification and lack of p53 point mutations in Hodgkin and Reed-Sternberg cells: results from single-cell polymerase chain reaction and molecular cytogenetic studies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Analysis of the p53 gene mutations in acute myelogenous leukemia: The p53 gene mutations associated with a deletion of chromosome 17

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Simultaneous detection of BCL-2 protein, trisomy 12, retinoblastoma and P53 monoallelic gene deletions in B-cell chronic lymphocytic leukemia by fluorescence in situ hybridization (FISH): relation to disease status

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Targeted disruption of p107: functional overlap between p107 and Rb

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

The Wilms tumor suppressor WT1 encodes a transcriptional activator of amphiregulin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Analysis of mutations of neurofibromatosis type 1 gene and N-ras gene in acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

E2F3 activity is regulated during the cell cycle and is required for the induction of S phase.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

The influence of INK4 proteins on growth and self-renewal kinetics of hematopoietic progenitor cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

WT1: what has the last decade told us?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Loss of p73 gene expression in lymphoid leukemia cell lines is associated with hypermethylation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Rb interacts with histone deacetylase to repress transcription

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Identification of candidate genes on chromosome band 20q12 by physical mapping of translocation breakpoints found in myeloid leukemia cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Transcriptional repression mediated by the WT1 Wilms tumor gene product

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Retinoblastoma protein represses transcription by recruiting a histone deacetylase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

P53 gene mutations in chronic myelogenous leukemia medullary and extramedullary blast crisis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Altered expression of p53 and mdm-2 proteins at diagnosis is associated with early treatment failure in childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Functional analysis of the p53 protein in AIDS-related non-Hodgkin's lymphomas and polymorphic lymphoproliferations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Rearrangement of the p53 gene in human osteogenic sarcomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

7q31-32 allelic loss is a frequent finding in splenic marginal zone lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Transcription factors C/EBP alpha, C/EBP beta, and CHOP (Gadd153) expressed during the differentiation program of keratinocytes in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Tumors in Rubinstein-Taybi syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Tandem duplications of the FLT3 receptor gene are associated with leukemic transformation of myelodysplasia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Aberrations of the p53 pathway components p53, MDM2 and CDKN2A appear independent in diffuse large B cell lymphoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Inverse correlation between Ink4-locus deletions and ICM-DNA hyperdiploidy in childhood acute lymphoblastic leukaemia, relation to clinical characteristics and outcome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Cyclin-dependent kinases: engines, clocks, and microprocessors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Mutations of the p53 gene in myelodysplastic syndrome and overt leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Mutation of the WT1 gene in myelodysplastic syndrome and acute myeloid leukaemia post myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

The Wilms tumor suppressor gene WT1 induces G1 arrest and apoptosis in myeloblastic leukemia M1 cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Retinoblastoma: Clues to Human Oncogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Genetic Alteration of p53 in Some Patients with Adult T-Cell Leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Identification and mapping of novel tumor suppressor loci on 6p in diffuse large B-cell non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Mutational analysis of the PTEN/MMAC1 gene in non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Prognostic value of p53 gene mutations and the product expression in de novo acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

p53 tumour suppressor gene and RAS oncogenes: molecular analysis in the chronic and leukaemic phases of essential thrombocythaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Alterations of multiple tumor suppressor genes (p53 (17p13), p16INK4 (9p21), and DBM (13q14)) in B-cell chronic lymphocytic leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

DNA methylation changes and multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

The challenge of p53 as prognostic and predictive factor in Hodgkin's or non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

wt1 gene expression in childhood leukemias

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Hematopoiesis in the fetal liver is impaired by targeted mutagenesis of a gene encoding a non-DNA binding subunit of the transcription factor, polyomavirus enhancer binding protein 2/core binding factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Genomic cloning of methylthioadenosine phosphorylase: a purine metabolic enzyme deficient in multiple different cancers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Role of the NF1 gene in leukemogenesis and myeloid growth control.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Amplification of a gene encoding a p53-associated protein in human sarcomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

RAS, FMS and p53 mutations and poor clinical outcome in myelodysplasias: a 10-year follow-up.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

WT1 and GATA1 expression in myelodysplastic syndrome and acute leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

WT1 mutations contribute to abnormal genital system development and hereditary Wilms' tumour

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

p53 dysfunction in B-cell chronic lymphocytic leukemia: inactivation of ATM as an alternative to TP53 mutation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Exhaustive analysis of the P53 gene coding sequence by denaturing gradient gel electrophoresis: application to the detection of point mutations in acute leukemias

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

E2F repression by C/EBPalpha is required for adipogenesis and granulopoiesis in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Clinical significance of p53 mutations in newly diagnosed Burkitt's lymphoma and acute lymphoblastic leukemia: a report of 48 cases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Rare occurrence of P53 gene mutations in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Inactivation of the retinoblastoma gene appears to be very uncommon in myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

The Wilms tumour (WT1) gene is mutated in a secondary leukaemia in a WAGR patient

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Transfer of p16inka/CDKN2 gene in leukaemic cell lines inhibits cell proliferation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Over-expression of the MDM2 gene is found in some cases of haematological malignancies.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

In vitro drug resistance and prognostic impact of p16INK4A/P15INK4B deletions in childhood T-cell acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Cell-extracellular matrix interactions can regulate the switch between growth and differentiation in rat hepatocytes: reciprocal expression of C/EBP alpha and immediate-early growth response transcription factors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

NF1 gene and neurofibromatosis 1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Direct interaction of hematopoietic transcription factors PU.1 and GATA-1: functional antagonism in erythroid cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Lack of MDM2 amplification in human leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

p107 is a suppressor of retinoblastoma development in pRb-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

P53 tumor suppressor gene in chronic myelogenous leukemia: a sequential study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Genetic studies of childhood acute lymphoblastic leukemia with emphasis on p16, MLL, and ETV6 gene abnormalities: results of St Jude Total Therapy Study XII

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Anomalous retinoblastoma protein expression in Sternberg-Reed cells in Hodgkin's disease: a comparative study with p53 and Ki67 expression.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Identification of a commonly deleted region at 17p13.3 in leukemia and lymphoma associated with 17p abnormality

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Insertional inactivation of the WT1 gene in tumour cells from a patient with WAGR syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Expression of the retinoblastoma tumor suppressor gene (RB-1) in acute leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Mantle cell lymphoma is characterized by inactivation of the ATM gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Prognostic significance of WT1 gene expression at diagnosis in adult de novo acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Loss of Fas (CD95/APO-1) regulatory function is an important step in early MALT-type lymphoma development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Analysis of the p53 and MDM-2 gene in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

A potent transrepression domain in the retinoblastoma protein induces a cell cycle arrest when bound to E2F sites

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

The tumor suppressor protein p16INK4a.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Role of the INK4a locus in tumor suppression and cell mortality.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Loss of the normal NF1 allele from the bone marrow of children with type 1 neurofibromatosis and malignant myeloid disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

A novel cofactor for p300 that regulates the p53 response

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Homozygous inactivation of the NF1 gene in bone marrow cells from children with neurofibromatosis type 1 and malignant myeloid disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Two tracks but one race? Cancer genetics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Keloids and neoplasms in the Rubinstein-Taybi syndrome.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Blastic transformation of p53-deficient bone marrow cells by p210bcr/abl tyrosine kinase.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Inactivation of ataxia telangiectasia mutated gene in B-cell chronic lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Molecular cytogenetic delineation of a novel critical genomic region in chromosome bands 11q22.3-923.1 in lymphoproliferative disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Expressed sequences as candidates for a novel tumor suppressor gene at band 13q14 in B-cell chronic lymphocytic leukemia and mantle cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Biallelic mutations in the ATM gene in T-prolymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Neurofibromatosis and childhood leukaemia/lymphoma: a population-based UKCCSG study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

FLT3, RAS, and TP53 mutations in elderly patients with acute myeloid leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Oncogenic aberrations in the p53 pathway are associated with a high S phase fraction and poor patient survival in B-cell Non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Expression of the retinoblastoma-related gene Rb2/p130 correlates with clinical outcome in endometrial cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Expression of the retinoblastoma-related gene Rb2/p130 is downregulated in atypical endometrial hyperplasia and adenocarcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Constitutive expression of the Wilms' tumor gene (WT1) in the leukemic cell line U937 blocks parts of the differentiation program

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

The ATM gene and susceptibility to childhood T-cell acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Genetic alterations in the retinoblastoma protein-related p107 gene in human hematologic malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

The Wilms' tumor gene WT1 is a good marker for diagnosis of disease progression of myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Immunohistochemical investigation of new suppressor oncogene p130 in oral squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Methylation of the p16INK4A gene in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Analysis of the CHK2 gene in lymphoid malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Methylation of the p15(INK4B) gene in myelodysplastic syndrome: it can be detected early at diagnosis or during disease progression and is highly associated with leukaemic transformation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

CCAAT/enhancer binding protein alpha regulates p21 protein and hepatocyte proliferation in newborn mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

CCAAT/enhancer-binding protein alpha (C/EBP alpha) inhibits cell proliferation through the p21 (WAF-1/CIP-1/SDI-1) protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Role of human Cds1 (Chk2) kinase in DNA damage checkpoint and its regulation by p53

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Analysis of p53 gene mutations in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

The prognostic significance of altered cyclin-dependent kinase inhibitors in human cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Mutations in the mitotic check point gene, MAD1L1, in human cancers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Hypermethylation of p16INK4A gene promoter during the progression of plasma cell dyscrasia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Clustering of missense mutations in the ataxia-telangiectasia gene in a sporadic T-cell leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

The CBFbeta subunit is essential for CBFalpha2 (AML1) function in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Mechanism of active transcriptional repression by the retinoblastoma protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Increased expression of the insulin-like growth factor I receptor gene, IGF1R, in Wilms tumor is correlated with modulation of IGF1R promoter activity by the WT1 Wilms tumor gene product

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Molecular analysis of the human chromosome 5q13.3 region in patients with hairy cell leukemia and identification of tumor suppressor gene candidates

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Search for rearrangements and/or allelic loss of the fas/APO-1 gene in 101 human lymphomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Deletions of p15 and/or p16 genes as a poor-prognosis factor in adult T-cell leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Expression of cell-cycle-associated proteins pRB2/p130 and p27kip in vulvar squamous cell carcinomas.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

The retinoblastoma gene (RB-1) status in multiple myeloma: a report on 35 cases.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein alpha-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Upregulation of interleukin 6 and granulocyte colony-stimulating factor receptors by transcription factor CCAAT enhancer binding protein alpha (C/EBP alpha) is critical for granulopoiesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Incidence and prognostic significance of MDM2 oncoprotein overexpression in relapsed childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021

Incidence and clinical significance of CDKN2/MTS1/P16ink4A and MTS2/P15ink4B gene deletions in childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205322

7 January 2021